SCHEMBL29529023

SCHEMBL29529023

CCCCOC(=O)c1cc(Br)cc(C(O)c2cc(Br)c(F)cc2F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 12/20 0.50
▸ AKR1C4 P17516 1/20 0.41
▸ AKR1C3 P42330 1/20 0.41
▸ AKR1C2 P52895 1/20 0.41
▸ AKR1C1 Q04828 1/20 0.41
▸ LMNA P02545 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ NR1H2 P55055 1/20 0.39
▸ RNASEL Q05823 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ PDE4D Q08499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29455727 0.83 NOTUM (0.48) LMNATSHRSMN1; SMN2MAPT
SCHEMBL29528789 0.81 NOTUM (0.36) —
SCHEMBL22400377 0.78 TTR (0.35) LMNAMAPK1SMN1; SMN2MAPT
SCHEMBL29529080 0.77 ESR1 (0.54) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL7592525 0.75 ESR1 (0.73) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL10180579 0.75 ESR1 (0.73) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13541203 0.72 ESR1 (0.68) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL7590980 0.70 ESR1 (0.66) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL18021136 0.70 ESR1 (0.54) ESR1LMNATSHRMAPK1CYP3A4
SCHEMBL19274492 0.70 ESR1 (0.65) ESR1AKR1C4AKR1C3AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946363-A2 GLUCOSE SENSITIVE INSULIN DERIVATIVES Novo Nordisk A/S (DK) 2022-02-09 — — EP disclosed
Send feedback